ALX Oncology Swaps 13.4 Million Shares For Pre-Funded Warrants, Mostly With Blackstone Funds

Funds tied to Blackstone Annex Master Fund account for most of the stock being traded in for warrants with a $0.001 exercise price.

Share
ALX Oncology Swaps 13.4 Million Shares For Pre-Funded Warrants, Mostly With Blackstone Funds

ALX Oncology agreed with certain stockholders to take back 13,353,384 shares of common stock and issue pre-funded warrants for the same number of shares, according to an 8-K filed Thursday. The exchange agreements were signed Wednesday.

What the 8-K says

Funds affiliated with Blackstone Annex Master Fund L.P. cover 12,885,891 of the shares. RA Capital Healthcare Fund, L.P. accounts for 213,667 and venBio Global Strategic Fund, L.P. for 253,826.

The company said the deals were privately negotiated, and that it relied on a Section 3(a)(9) exemption from registration under the Securities Act. The exchange is set to settle on or about October 15.

Each pre-funded warrant — a warrant whose price is nearly all paid up front — has an exercise price of $0.001 per share. Holders can exercise at any time until the warrant is used in full, either by paying cash or through a cashless exercise that yields a net number of shares under a formula in the warrant.

What it changes

The stockholders keep the economic exposure to the same number of shares, but hold it in warrant form. A form of the warrant filed as an exhibit says holders have no vote and no dividend rights as stockholders until they receive shares on exercise.

Exercise is capped. A holder, together with its affiliates, cannot exercise if it would own more than 4.99% or 9.99% of the stock, as each warrant specifies. A holder can move that limit to any level up to 19.99%, though an increase takes effect only on the 61st day after notice to the company.

The exhibit also sets a remedy for late delivery. If the company fails to deliver shares on time and the holder covers the gap with a buy-in purchase, the company must respond to the holder's written request within two trading days. It can be required to pay cash for the purchase cost.

ALXO shares stood at $1.00 in Thursday after-hours trading, unchanged from the regular close.

What to watch

The question is whether the holders exercise the warrants and turn them back into common stock, which the terms allow at any time within the ownership caps.

Settlement of the exchange is set for on or about October 15, the date the filing gives.

Sources

More on ALX Oncology Holdings

All ALX Oncology Holdings (ALXO) coverage →